Refine by
Drug Industry Articles & Analysis
52 news found
Conducted in accordance with OECD Guidelines for Testing of Chemicals, Test No. 471, the bacterial reverse mutation test (Ames) uses histidine-dependent strains of Salmonella typhimurium or Escherichia coli to detect permanent gene mutations (e.g., single or multiple base pair substitutions, insertions or deletions) caused by new chemicals and candidate drugs. To support the ...
BySTEMart
BOC Sciences adds to its participation agenda the prestigious Drug Discovery Chemistry 2025 Conference (April 14-17, 2025), which will be a hybrid event taking place in San Diego, CA, and will offer virtual access for worldwide attendees Drug Discovery Chemistry is a heavyweight industry event. ...
However, industry and research laboratories face challenges in analyzing complex and diverse samples and require sensitive and reliable drug delivery systems to provide consistent results in support of analytical studies and assays. ...
CD Bioparticles is committed to providing innovative and high-quality drug delivery solutions for various industries. The company's liposomes for food applications can be used to encapsulate a wide range of ingredients, including vitamins, minerals, and nutraceuticals, representing a significant advancement in the field of food technology. ...
CD Formulation is making waves in the pharmaceutical industry with its innovative drug delivery technologies. With a focus on sustained and controlled release formulations, as well as liquid, semi-solid, injectable, and nanoformulations, CD Formulation is at the forefront of the industry's efforts to enhance drug efficacy. ...
DDC is an annual event that gathers researchers, scientists, and experts from across the globe who are involved in the dynamic field of drug discovery. DDC builds a perfect bridge for thought-sharing and networking, reputed to be a must-attend conference for everyone in the drug discovery industry. ...
This accuracy reduces the risk of over or under-dosing and improves therapeutic outcomes. The advantages of this drug delivery system extend beyond patient convenience and precise dosing, as the technology also enhances the bioavailability of drugs. ...
With a focus on precision and efficiency, CD Formulation has propelled itself to the forefront of drug delivery system development. Their dedication to improving patient outcomes and streamlining treatment procedures has earned them a stellar reputation among industry experts. ...
The screening of substrates, inhibitors, and other ligands is a pivotal facet of enzyme research, enabling scientists to pinpoint compounds best suited for a variety of applications, from drug development to industrial processes. A profound understanding of enzyme-molecule interactions can pave the way for groundbreaking therapies, improved bioprocessing, and the ...
Recently, the company introduced a series of state-of-the-art services in Drug Design and Computer-Aided Drug Design (CADD) with the aim of providing efficient and reliable solutions for the pharmaceutical industry's drug development endeavors. Drug Design is a crucial discipline in pharmaceutical research that ...
We seize every opportunity to apply the latest science and technology to the pharmaceutical industry through our diversified drug analysis service portfolios in the hope of advancing the global healthcare business," said a spokesperson for CD Formulation. ...
BOC Sciences, a leading CRO in the USA, unveils its comprehensive capabilities for custom peptide drug conjugate from project design to commercial production. With its well-established conjugation platform, BOC Sciences supports pharmaceutical and biotechnology clients at the forefront of drug conjugation. Peptide-drug conjugates (PDCs) are ...
The senior management team contributes extensive industry knowledge and leadership in biologics drug discovery and development, data science, and business development. ...
Wang Xinlun, Vice President and Secretary-General of China Association for STD and AIDS Prevention and Treatment, industry experts and representatives of partner companies and institutions attended the ceremony. ...
Attend industry events. In addition to conferences put on by professional organizations, there are also many industry-specific events, such as the Drug Information Association (DIA) Annual Meeting and BIO International Convention. ...
The company's risk-sharing partnership offerings allow organizations to co-develop new drugs using BIOiSIM™ and, hence, predict translation from bench to bedside, reduce R&D costs, lower the risk of selecting new drug candidates, and condense the development time for promising drugs. According to Aarti Chitale, a Frost & Sullivan ...
The appointment of former Merck, Sharp and Dohme (MSD) Director of R&D Analytics supports continued innovation of Optibrium’s AI drug discovery software Optibrium a leading developer of software and AI solutions for drug discovery, today announced the appointment of Ian Smith as Chief Technology Officer (CTO), the latest in a number of senior-level ...
Technologies like our unique Translational Index™, which synthesizes the potential for clinical success of any drug candidate, enable smarter decisions about how to advance drug asset programs and ultimately improve the lives of patients in ...
With the boom of nanotechnology, a growing number of nanomaterials have been applied to the pharmaceutical industry. For instance, nanoparticle-based drug delivery has become research of interest. ...
The potential applications are subject to the requisite clinical and regulatory commercialization processes. The global psychedelic drugs market is expected to gain significant market growth in the forecast period from 2022 to 2029. ...